If it is Gilead that they the most promising drug for treatment at the moment, they are currently in trials that are expected to be released at the end of May.
Cant see where the tie would be between a global biotech company and a small medicinal marijuana manufacturer. So expect it is something else.
Ann: Trading Halt, page-10
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4408 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 1899 | 2 |
View Market Depth
| Last trade - 16.12pm 08/11/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable